首页> 外国专利> Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of vaccines antipertussicas.

Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of vaccines antipertussicas.

机译:百日咳毒素突变体,能够产生这种突变体的博德特氏菌菌株及其在抗百日咳疫苗的开发中的用途。

摘要

These mutants (PT) ARE immunologically active, having reduced or no toxicity, and are characterized in that at least one of the amino acid residues Glu129, ASP11, TRP26, Arg 9, Fe50, ASP1, Arg13, TYR130, GLY86, LLE88, TIR44, THR53 and Gly80 subunit amino acid is deleted and replaced by a residue different amino acid. Bordetella CHAINS AND SEPARATE capable of providing such mutant PT and meaning and methods for obtaining them are also described. STRINGS AND Bordetella mutants produced are particularly suitable for the preparation of vaccines CELLULAR AND VACCINE PERTUSSIS acellular.
机译:这些突变体(PT)具有免疫活性,具有降低的毒性或没有毒性,并且特征在于氨基酸残基Glu129,ASP11,TRP26,Arg 9,Fe50,ASP1,Arg13,TYR130,GLY86,LLE88,TIR44中的至少一个,THR53和Gly80亚基氨基酸被删除并被残基不同的氨基酸取代。还描述了能够提供这种突变体PT的博德特氏菌链和分离物以及获得它们的意义和方法。产生的链和博德特氏菌突变体特别适合于制备脱细胞的细胞和疫苗百日咳疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号